Gene editing using CRISPR/Cas9 tools could potentially be a therapeutic option not only for this 10% of PwCF but also for all PwCF. CRISPR/Cas9 tool could potentially lead to a cure for CF.
Research Solutions
Monoclonal antibodies, or mAb, are one of the preferred treatment options for many unmet need diseases…
How to select the company to manufacture your antibody drug SYNIMMUNE GmbH is a biotechnology…